CLIENT NEWS
- InflaRx Full Year 2018 Financial & Operating Results28 March 2019
- Probiodrug reports full year 2018 financial results28 March 2019
- Heidelberg Pharma to present its proprietary ATAC technology platform at the AACR Annual Meeting 201927 March 2019
- Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome26 March 2019
- Motif Bio plc: Proposed Equity Fundraise25 March 2019
- Adrenomed’s Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II21 March 2019
- MagForce AG successfully completes installation of mobile NanoTherm treatment center for brain tumors in Poland21 March 2019
- Breath Therapeutics Announces Presentations at Upcoming Scientific Conferences20 March 2019
- Topas Therapeutics to Participate at Upcoming Industry and Scientific Conferences20 March 2019
- Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim20 March 2019